Cargando…
A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals
BACKGROUND: Ayurveda, the Indian system of medicine offers many herbs and formulations for management of obesity. Baidyanath Bhawan Pvt. Ltd has designed a formulation, HFO-02, based on Ayurvedic literature. OBJECTIVE: To evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329718/ https://www.ncbi.nlm.nih.gov/pubmed/31474325 http://dx.doi.org/10.1016/j.jaim.2019.05.003 |
_version_ | 1783552954163265536 |
---|---|
author | Gupte, Poonam Harke, Shubhangi Deo, Veena Bhushan Shrikhande, Bharat Mahajan, Madhavi Bhalerao, Supriya |
author_facet | Gupte, Poonam Harke, Shubhangi Deo, Veena Bhushan Shrikhande, Bharat Mahajan, Madhavi Bhalerao, Supriya |
author_sort | Gupte, Poonam |
collection | PubMed |
description | BACKGROUND: Ayurveda, the Indian system of medicine offers many herbs and formulations for management of obesity. Baidyanath Bhawan Pvt. Ltd has designed a formulation, HFO-02, based on Ayurvedic literature. OBJECTIVE: To evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals. MATERIALS & METHODS: With approval from the Institutional Ethics Committee, a proof of concept study was carried out in overweight individuals (Body Mass Index, BMI ≥25.0 and ≤ 30.0 kg/m(2)), devoid of any endocrinological disorders. Tablet HFO-02 (500 mg) was administered to these individuals twice daily for 90 days, during which they were called at study site fortnightly. After stopping the treatment, they were further followed up for 30 days off-medication and the last follow up was scheduled on day 120. Anthropometric parameters were assessed at every visit, while biochemical parameters viz. lipid profile, blood sugar & insulin levels (both fasting and post prandial), C- reactive protein and adipocytokines (leptin & adiponectin) were estimated monthly. RESULTS: Of the 18 participants recruited in the study; 14 completed the study. HFO-02 did not show reduction in weight, however a significant decrease in the body circumference and skin fold was demonstrated. This decrease was maintained till day 120. The levels of all biochemical parameters were maintained and no adverse events were reported throughout the study. CONCLUSION: Tablet HFO-02 reduced body circumferences and skinfold thickness indicating its potential for obesity management. CLINICAL TRIAL REGISTRATION NUMBER: CTRI/2016/07/007067. |
format | Online Article Text |
id | pubmed-7329718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-73297182020-07-06 A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals Gupte, Poonam Harke, Shubhangi Deo, Veena Bhushan Shrikhande, Bharat Mahajan, Madhavi Bhalerao, Supriya J Ayurveda Integr Med Original Research Article- Clinical BACKGROUND: Ayurveda, the Indian system of medicine offers many herbs and formulations for management of obesity. Baidyanath Bhawan Pvt. Ltd has designed a formulation, HFO-02, based on Ayurvedic literature. OBJECTIVE: To evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals. MATERIALS & METHODS: With approval from the Institutional Ethics Committee, a proof of concept study was carried out in overweight individuals (Body Mass Index, BMI ≥25.0 and ≤ 30.0 kg/m(2)), devoid of any endocrinological disorders. Tablet HFO-02 (500 mg) was administered to these individuals twice daily for 90 days, during which they were called at study site fortnightly. After stopping the treatment, they were further followed up for 30 days off-medication and the last follow up was scheduled on day 120. Anthropometric parameters were assessed at every visit, while biochemical parameters viz. lipid profile, blood sugar & insulin levels (both fasting and post prandial), C- reactive protein and adipocytokines (leptin & adiponectin) were estimated monthly. RESULTS: Of the 18 participants recruited in the study; 14 completed the study. HFO-02 did not show reduction in weight, however a significant decrease in the body circumference and skin fold was demonstrated. This decrease was maintained till day 120. The levels of all biochemical parameters were maintained and no adverse events were reported throughout the study. CONCLUSION: Tablet HFO-02 reduced body circumferences and skinfold thickness indicating its potential for obesity management. CLINICAL TRIAL REGISTRATION NUMBER: CTRI/2016/07/007067. Elsevier 2020 2019-08-29 /pmc/articles/PMC7329718/ /pubmed/31474325 http://dx.doi.org/10.1016/j.jaim.2019.05.003 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Article- Clinical Gupte, Poonam Harke, Shubhangi Deo, Veena Bhushan Shrikhande, Bharat Mahajan, Madhavi Bhalerao, Supriya A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals |
title | A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals |
title_full | A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals |
title_fullStr | A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals |
title_full_unstemmed | A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals |
title_short | A clinical study to evaluate the efficacy of Herbal Formulation for Obesity (HFO-02) in overweight individuals |
title_sort | clinical study to evaluate the efficacy of herbal formulation for obesity (hfo-02) in overweight individuals |
topic | Original Research Article- Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329718/ https://www.ncbi.nlm.nih.gov/pubmed/31474325 http://dx.doi.org/10.1016/j.jaim.2019.05.003 |
work_keys_str_mv | AT guptepoonam aclinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT harkeshubhangi aclinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT deoveena aclinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT bhushanshrikhandebharat aclinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT mahajanmadhavi aclinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT bhaleraosupriya aclinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT guptepoonam clinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT harkeshubhangi clinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT deoveena clinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT bhushanshrikhandebharat clinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT mahajanmadhavi clinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals AT bhaleraosupriya clinicalstudytoevaluatetheefficacyofherbalformulationforobesityhfo02inoverweightindividuals |